Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Skin Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

fludarabine phosphate 12Peripheral Blood Stem Cell Transplantation 12Cyclosporine 11Cyclophosphamide 11Whole-Body Irradiation 10Filgrastim 8Mycophenolic Acid 7Busulfan 6Antilymphocyte Serum 6Melphalan 5Rituximab 4Radiotherapy 4Psychiatric Rehabilitation 4Methylprednisolone 4Etoposide 4Therapeutics 3Methotrexate 3Granulocyte Colony-Stimulating Factor 3Cord Blood Stem Cell Transplantation 3Aprepitant 3Analgesia 3plerixafor 2fludarabine 2Ondansetron 2Flow Cytometry 2Dexamethasone 2Carmustine 2Calcium Dobesilate 2Bortezomib 2zanubrutinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, B-Cell, Marginal Zone × Amoxicillin × Clear all
NCT00201422 2016-03-28

Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma

National Health Research Institutes, Taiwan

Phase NA Completed
70 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡